Previous Page  8 / 20 Next Page
Information
Show Menu
Previous Page 8 / 20 Next Page
Page Background

Page 18

Pediatrics & Neonatal Healthcare 2017

http://pediatrics.cmesociety.com

September 11-12, 2017 Los Angeles, CA, USA

14

th

World Pediatrics &

Neonatal Healthcare Conference

Journal of Pediatric Health Care and Medicine Volume 1, Issue 1

Notes:

Can MCA Doppler studies predict mortality in fetuses with congenital hydrocephalus?

Bahauddin Ibraheem Sallout

Women’s Specialized Hospital- King Fahad Medical City, Saudi Arabia

Objective:

The objective of this study is to investigate the impact of abnormal middle cerebral artery (MCA)

Doppler on the perinatal mortality in fetuses with congenital hydrocephalus (CH).

Methods:

A prospective study of all fetuses with CH who delivered at our hospital over a period of 7 years. Data

were obtained from the ultrasound, labor room and intensive neonatal care unit (NICU) database. The Perinatal

mortality rates were evaluated in relation to the following measures, associated congenital anomalies, cortical

mantle thickness (CMT), and MCA Doppler abnormalities (absent or reversed diastole). The main outcome

measure was perinatal mortality rate in relation to MCA Doppler changes.

Results:

A total of 85 cases of CH were diagnosed and managed. The birth prevalence of CH was 2.44 per 1000

live births. On one hand, the perinatal mortality rate was higher in those fetuses with non-isolated hydrocephalus,

(37.25% (19/51) versus (35.29% (12/34, p¼0.854 and in those cases with CMT <10 mm, 38.78% (19/49) versus

33.33% (12/36) in those with CMT >10 mm, p¼0.607. On the other hand, the perinatal mortality rate was

significantly higher in those fetuses with abnormal MCADoppler, (100% (13/13) versus 25% (18/72), OR¼78.0,

95% CI (5.52–44085124.60), p<0.001.

Conclusions:

Abnormal fetal MCA Doppler (absent or reversed diastole) appears to be a poor prognostic

indicator with significantly high perinatal mortality in fetuses with CH.

Biography

Dr. Sallout is a certified Maternal-Fetal Medicine (MFM) consultant from university of Ottawa, Canada, with American Specialty in Ultrasound in Obstetrics and

Gynecology. He has special training in fetal echocardiograph and 3D/4D sonography. He developed the ultrasound Unit and established the MFM department,

and currently, the Medical Director for the Women’s Specialized Hospital, King Fahad Medical City. Riyadh, Saudi Arabia. He has 17 publications in the field of

obstetrics ultrasound and fetal medicine, and he participated and presented in many international and local conferences.

bsallout@kfmc.med.sa